Search Results 731-740 of 17098 for egfr

1. An Adjuvant Study To Evaluate SMS001 (Paclitaxel) In Non-Small Cell Lung Cancer - Mayo Clinic

   eGFR \>60mL/min/1.73m² 7. QT interval corrected for heart rate using Frederica's formula (QTcF): males \< 450msec and females \< 470msec 8. Operating ...

2. A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations - Mayo Clinic

   The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary effectiveness of KIN-3248, an oral small molecule FGFR ...

3. End-stage renal disease - Doctors and departments - Mayo Clinic

   When kidneys no longer function well enough to meet a body's needs, treatment involves kidney dialysis or kidney transplant.

4. Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) - Mayo Clinic

   Severe kidney disease (as defined by estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2). Known hepatitis B, hepatitis C or HIV infection ...

5. Dose Response Study of GSK2330672 for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis - Mayo Clinic

   Screening eGFR <45 milliliter (mL)/minute/1.73 meter squared (m^2) based on the CKD-EPI. History or presence of hepatic decompensation (e.g., variceal ...

6. Efficacy of KL1333 in adult patients with primary mitochondrial disease - Mayo Clinic

   estimated glomerular filtration rate (eGFR) calculated by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine equation <30 mL/min/1.73 m2 ...

7. Esophageal Cancer Clinical Trials - Mayo Clinic Research

   The purpose of this study is to demonstrate the safety and tolerability of JAB-3312 in combination with anti-PD-1 mAb or MEKi or KRASi or EGFR-TKI in patients ...

8. Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta - Mayo Clinic

   range). - Renal disease: Estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m^2 (calculated by the bedside Schwartz equation at screening) eGFR (mL/min ...

9. A Study of the Safety and Effectiveness of HBI-8000 with Nivolumab to Treat Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer - Mayo Clinic

   NSCLC subjects with EGFR or ALK genomic aberrations in tumor should have disease progression on FDA-approved therapy for these aberrations prior to receiving ...

10. A Study to Learn More About Using Different Markers to Assess Kidney Function in Patients Before and After Methotrexate Therapy - Mayo Clinic

    The purpose of this study is to investigate the role that cystatin C and other novel renal biomarkers can have on improving the dosing and monitoring of adults ...